자폐스펙트럼장애의 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구 -기존에 개발된 자폐스펙트럼장애 가이드라인을 중심으로-
A Basic Study for Development of Clinical Practice Guidelines of Korean Medicine in Autism Spectrum Disorder -Based on Pre-existing Clinical Practice Guidelines of Autism Specturm Disorder-
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives The purpose of this study is to review pre-existing clinical practice guidelines for autism spectrum disorders, and refer those in developing a new practice guideline. Methods A total of 9 existing clinical practice guidelines for autism spectrum disorder developed from 2010 to 2016 were searched by Google scholar and Pubmed, and were reviewed those literatures in three parts: general, diagnosis & evaluation, and intervention. Results There were no consistency in the recommendation methods of 9 clinical care guidelines (such as the method of rating and recommendation intensity for diagnosis, evaluation, and treatment). However, in the diagnosis and evaluation section, frequently used evaluation and diagnostic tools are mentioned in most clinical practice guidelines, and the types of pharmacologic and non-pharmacological treatments that are mainly recommended in treatment are equally mentioned in most clinical practice guidelines could confirm. Conclusions 1. Some guideline recommendations are graded according to each criterion. Recommendations presented in various databases were based on systematic reviews or other literatures. The most utilized database were PsycINFO, CINAHL, Cochrane. 2. DSM-5 and ICD-10 were the most common used diagnostic criteria, and DSM-IV was used as a diagnostic standard in the guideline published before 2013. The tools used for diagnosis and evaluation were also varied. However, most recommended ones were ADI-R, ADOS-G, and DISCO. 3. Treatment was largely divided into pharmacological intervention and non-pharmacological intervention. In some guideline, the interventions were divided into pediatric and adult. Most of the pharmacological interventions were not recommended due to lack of evidence, but in cases in which specific symptoms were aimed, they recommended to seek professional help. 4. In addition to interventions, each guideline referred to supportive interventions that may be helpful in the daily life of patients with ASD, which may need to be addressed in future clinical guidelines.
Abstract
Objectives The purpose of this study is to review pre-existing clinical practice guidelines for autism spectrum disorders, and refer those in developing a new practice guideline. Methods A total of 9 existing clinical practice guidelines for autism spectrum disorder developed from 2010 to 2016 were searched by Google scholar and Pubmed, and were reviewed those literatures in three parts: general, diagnosis & evaluation, and intervention. Results There were no consistency in the recommendation methods of 9 clinical care guidelines (such as the method of rating and recommendation intensity for diagnosis, evaluation, and treatment). However, in the diagnosis and evaluation section, frequently used evaluation and diagnostic tools are mentioned in most clinical practice guidelines, and the types of pharmacologic and non-pharmacological treatments that are mainly recommended in treatment are equally mentioned in most clinical practice guidelines could confirm. Conclusions 1. Some guideline recommendations are graded according to each criterion. Recommendations presented in various databases were based on systematic reviews or other literatures. The most utilized database were PsycINFO, CINAHL, Cochrane. 2. DSM-5 and ICD-10 were the most common used diagnostic criteria, and DSM-IV was used as a diagnostic standard in the guideline published before 2013. The tools used for diagnosis and evaluation were also varied. However, most recommended ones were ADI-R, ADOS-G, and DISCO. 3. Treatment was largely divided into pharmacological intervention and non-pharmacological intervention. In some guideline, the interventions were divided into pediatric and adult. Most of the pharmacological interventions were not recommended due to lack of evidence, but in cases in which specific symptoms were aimed, they recommended to seek professional help. 4. In addition to interventions, each guideline referred to supportive interventions that may be helpful in the daily life of patients with ASD, which may need to be addressed in future clinical guidelines.
참고문헌 (39)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Association
- Baxter AJ, "The epidemiology and global burden of autism spectrum disorders", Psychol Med, 45, pp.601~ (2015)
- Fombonne E, "Epidemiology of pervasive developmental disorders", Pediatr Res, 65, pp.591~ (2009)
- Centers for Disease Control and Prevention, "Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years-United States, 2003-2004", MMWR Morb Mortal Wkly Rep, 55, pp.481~ (2006)
- Maglione MA, "HRSA autism intervention research–behavioral (AIR-B) network. Nonmedical interventions for children with ASD: recommended guidelines and further research needs", Pediatr, (130Suppl2), pp.S169~S178 (2012)
- Myers SM, "American Academy of Pediatrics Council on Children With Disabilities. Management of children with autism spectrum disorders", Pediatr, 120, pp.1162~ (2007)
- Hwang EW, "Haneuisingyungjungsingwahak", pp.444~ (2011), Jip Moon Dang Publishing co
- Hanson E, "Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder", J Autism Dev Disord, 37, pp.628~ (2007)
- Akins RS, "Utilization patterns of conventional and complementary", alternative treatments in children with autism spectrum disorders and developmental disabilities in a population-based study, 2014, pp.35(1), 1~10
- Levy SE, "Complementary and alternative medicine treatments for children with autism spectrum disorders", Child Adolesc Psychiatr Clin N Am, 17, pp.803~ (2008)
- "Assessment, diagnosis and interventions for autism spectrum disorders", Scottish Intercollegiate Guidelines Network, ~ (2016)
- "Autism spctrum disorder in under 19s: recognition, referral and diagnosis", National Institute for Health and Care Excellence, ~ (2016)
- "Autism spectrum disorder in under 19s: support and management", National Institute for Health and Care Excellence, ~ (2011)
- "Autism spectrum disorder in adults: diagnosis and management", National Institute for Health and Care Excellence, ~ (2013)
- Volkmar F, "Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder", J Am Acad Child Adolesc Psychiatry, 53(2), pp.237~257 (2014)
- "Best Practice Guidelines for the Assessment and Diagnosis of Autistic Spectrum Disorders for children and adolescents (birth to 18 years)", Psychological Society of Ireland, ~ (2010)
- "Autism Spectrum Disorders: Missouri Best Practice Guidelines for Screening, Diagnosis, and Assessment. Missouri Autism Guidelines Initiative", ~ (2010)
- "Autism Spectrum Disorders: Guide to Evidence-based Interventions", Missouri Autism Guidelines Initiative, ~ (2012)
- "New Zealand Autism Spectrum Disorder Guideline", Minitsries of Health and Education in New Zealand, ~ (2016)
- Kanner L., "Autistic disturbances of affective contact", Neurodiversity, pp.217~250 (1943)
- Ahn HS, "Textbook of pediatrics", pp.43~ (2016), MiraeN Publishing co
- Lee JY, "Oriental medical treatment for autistic disorder(focused on mind-spirit therapy and speech therapy)", J Pediatr Korean Med, 8(1), pp.157~163 (1994)
- "New Zealand Autism Spectrum Disorder Guideline Supplementary Paper on Implications of DSM-5 for the Diagnosis of ASD. Christchurch: INSIGHT Research" (2014)[URL]
- Volkmar FR, "Autism in DSM-5 : progress and challenges", Mol Autism, 4(1), pp.13~18 (2013)
- Tadevosyan-Leyfer O, "A principal components analysis of the Autism Diagnostic Interview-Revised", J Am Acad Child Adolesc Psychiatry, 42(7), pp.864~872 (2003)
- Rutter M, "Social Communication Questionnaire" (2003), Western Psychological Services
- Lord C, "The autism diagnostic observation schedule-generic : a standard measure of social and communication deficits associated with the spectrum of autism", J Autism Dev Disord, 30(3), pp.205~223 (2000)
- Lord C, "Autism Diagnostic Observation Schedule Manual-2", Western Psychological Services, ~ (2012)
- Wing L, "The diagnostic interview for social and communication disorders : background, inter-rater reliability and clinical use", J Child Psychol Psychiatry, 43, pp.307~325 (2002)
- Leekam S, "Diagnostic interview for social and communication disorders", Encycl Autism Spectr Disord, pp.926~931 (2013)
- Hollander E, "Targeted treatments for symptom domains in child and adolescent autism", Lancet, 362(9385), pp.732~734 (2003)
- Myers SM, "American Academy of Pediatrics Council on Children with Disabilities. Management of children with autism spectrum disorders", Pediatr, 120(5), pp.1162~1182 (2007)
- Leskovec TJ, "Pharmacological treatment options for autism spectrum disorders in children and adolescents", Harv Rev Psychiatry, 16(2), pp.97~112 (2008)
- 이지나, "자폐스펙트럼장애의 침치료에 대한 최근 임상 연구 동향- RCT 중심으로 -", 대한한방소아과학회지, 29(4), pp.119~126 (2015), 대한한방소아과학회
- 이진화, "자폐증 한방 치료에 대한 최신 임상 연구 고찰 - 중의학 논문 중심으로 -", 대한한방소아과학회지, 28(4), pp.85~95 (2014), 대한한방소아과학회
- Agnew F, "Pacific models of mental health service delivery in New Zealand project", HRC, ~ (2004)
- Matson JL, "Autism spectrum disorders : management over the lifespan", Expert Rev Neurother, 16(11), pp.1301~1310 (2016)
- 이소현, "자폐 범주성 장애 진단 및 지원 체계 수립 요구: 소아청소년정신과 전문의의 경험과 인식을 중심으로", 자폐성장애연구, 14(3), pp.131~169 (2014), 한국자폐학회